Levi Strauss & Co. vs Tilray Brands Inc — how do they compare? Levi Strauss & Co. trades at $24.59 (market cap $9.21B), while Tilray Brands Inc trades at $4.25 (market cap $524.07M). The key difference: Levi Strauss & Co. is far larger — about 17.6× Tilray Brands Inc's market cap, and Levi Strauss & Co. pays a 2.68% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| LEVI | TLRY | |
|---|---|---|
Market Cap | $9.21B | $524.07M |
Sector | Consumer Cyclical | Health |
52-Week High | $24.99 | $21.00 |
52-Week Low | $17.92 | $4.23 |
Enterprise Value | $10.52B | $621.22M |
Dividend Yield | 2.68% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.
The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.
Trailing returns across standard periods
Latest headlines on both assets
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →